Form D — Pace Pharmaceuticals, Inc.
0002157304-26-000001 · filed Sep 28, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- —
- Total sold
- $50,000
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pace Pharmaceuticals, Inc.
- CIK
- 2157304
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 10360 SCENIC BLVD.
CUPERTINO, CA 95014 - Phone
- 4085104019
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Douglas Wang Yao · Executive OfficerCupertino, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗